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Abstract
Health and nutrition modulate postnatal growth. The availability of amino acids and energy, 
and insulin and insulin- like growth factor- I (IGF- I) regulates early growth through the mTOR 
pathway. Amino acids and glucose also stimulate the secretion of IGF- I and insulin. Postnatal 
growth induces lasting, programming effects on later body size and adiposity in animals 
and in human observational studies. Rapid weight gain in infancy and the first 2 years was 
shown to predict increased obesity risk in childhood and adulthood. Breastfeeding leads to 
lesser high weight gain in infancy and reduces obesity risk in later life by about 20%, pre-
sumably partly due to the lower protein supply with human milk than conventional infant 
formula. In a large randomized clinical trial, we tested the hypothesis that reduced infant 
formula protein contents lower insulin- releasing amino acid concentrations and thereby 
decrease circulating insulin and IGF- I levels, resulting in lesser early weight gain and reduced 
later obesity risk (the ‘Early Protein Hypothesis’). The results demonstrate that lowered pro-
tein in infant formula induces similar – but not equal – metabolic and endocrine responses 
and normalizes weight and BMI relative to breastfed controls at the age of 2 years. The 
results available should lead to enhanced efforts to actively promote, protect and support 
breastfeeding. For infants that are not breastfed or not fully breastfed, the use of infant for-
mulas with lower protein contents but high protein quality appears preferable. Cows’ milk 
as a drink provides high protein intake and should be avoided in infancy.
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12 Koletzko et al.
Growth and development are key characteristics of childhood and sensitive mark-
ers of health status and adequate nutrition. Pediatricians regularly monitor the 
growth patterns of children as part of standard routine care, usually by plotting 
repeated growth measures over time on percentile reference curves to derive lon-
gitudinal growth patterns. Traditionally, this approach served primarily to early 
detect growth faltering as a marker of the presence of infectious and other dis-
eases, or of inadequate nutrition, which show particularly rapid adverse effects on 
growth in infancy and early childhood [1]. More recently, however, the impact of 
excessive growth on child health has been receiving increasing attention [2–4].
In 1989, Karlberg [5] described the Infancy- Childhood- Puberty Growth 
Model (ICP model) of growth, and proposed the key drivers of growth to be age 
dependent. Karlberg concluded that pubertal growth is primarily driven by sex 
hormones, whereas prepubertal growth is regulated primarily by human growth 
hormone (hGH) acting through the release of insulin- like growth factor- I (IGF- 
I). In addition, dietary factors and especially the intakes of energy and protein 
are very important regulators of serum IGF- I concentrations and its biological 
activity, especially during the first months of infancy [6]. Amino acids were also 
reported to be more potent stimulators of IGF- I release than glucose [7]. For 
example, studies in 4- week- old rats showed that feeding a diet with 15 instead of 
5% protein for only one week increased serum IGF- I more than 4- fold [8]. With 
increasing age of the child, there appears to be a gradual transition to a more 
important role of hGH in the regulation of IGF- I, along with increasing concen-
trations of growth hormone- binding proteins that are considered to reflect hGH 
receptor numbers [9, 10]. Nutrition also markedly influences insulin secretion 
which has key regulatory roles for anabolic pathways as well as tissue and lipid 
deposition during early growth [11, 12]. Glucose concentration is a key driver 
of insulin secretion, but the glucose- induced insulin secretion was shown to be 
markedly attenuated by a low protein supply [13]. Amino acids such as leucine 
also enhance insulin secretion via both acute effects, such as activated glutamate 
dehydrogenase activity, and chronic effects such as gene transcription and regu-
lation of β- cell metabolism [14].
One pathway though which nutrients as well as the growth factors insulin and 
IGF- I can effectively modulate growth and metabolism is the mammalian target 
of rapamycin (mTOR), a highly conserved Ser/Thr kinase present in two structur-
ally and functionally distinct complexes [15]. The mTORcomplex 1 (mTORC1) 
contains mTOR, mLST8, and raptor, whereas mTORC2 is composed of mTOR, 
mLST8, rictor, mSIN1, and PRR5. The growth factors insulin and IGF- I stimulate 
mTORC2 via an unknown pathway, and mTORC1 via PI3K and Akt inducing the 
mTORC1 activator Rheb [15]. Amino acids enhance ATP loading of RAG pro-
teins and RAG- GTPases, which interact with Rheb and activate mTORC1 [15]. 
Of importance, full activation of mTORC1 is only achieved through the syner-
gistic action of both growth factors and amino acids, while a low energy supply 
downregulates mTORC1 [15]. Thus, this pathway represents an elaborate sensor 
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Early Influences of Nutrition on Postnatal Growth 13
system by which nutritional supply regulates metabolism and growth. The enor-
mous power of this system is demonstrated, for example, in mice with knockout 
of raptor in adipose tissue, which leads to disruption of mTORC1. These mice 
are lean and resistant to diet- induced obesity, and they have improved metabolic 
characteristics such as better glucose tolerance and insulin sensitivity, as well as 
resistance to diet- induced hypercholesterolemia [16]. These observations lead us 
to the conclusion that regulation of mTORC1 signaling by amino acids controls 
whole- body energy metabolism, bodyweight and body composition. Therefore, 
the current knowledge on the physiological mechanisms regulating metabolism, 
growth and related outcomes relevant for health indicate the large potential that 
improved nutritional practice during early life can have on long- term disease pre-
vention and well- being, a concept widely known as early nutritional program-
ming of life- long health [17–23]. Results of a recent randomized intervention trial 
in human infants demonstrate the powerful effects of modifying protein supply 
on metabolic and endocrine response as well as growth [24].
Postnatal Diet, Growth Patterns, and the Later Risk of Obesity and Related 
Non- Communicable Diseases
In early systematic studies performed already in the 1960s, McCance and 
Widdowson [25] demonstrated programming effects of food restriction for 3 
weeks in the early life of animals which led to permanent reduction of bodyweight 
up to adulthood, whereas no such permanent effects were induced when the same 
degree of food restriction was induced at a later age. In humans, such postnatal 
programming effects on later body size have also been reported [26]. Both high 
birthweight and high weight gain in the first 2 years of life are associated with 
increased risk for later obesity, as reviewed in Koletzko et al. [27]. For example, 
we found early growth patterns predictive of overweight risk at school age in a 
study on 4,235 German children aged 5–6 years that were participating in the 
obligatory school entry health examination in Bavaria, Germany. Data on early 
gains of weight, length, body mass index (BMI) and Ponderal Index were derived 
from the measurements taken during the preventive health care checks offered 
to all children at birth, 6, 12 and 24 months [28]. Overweight at school entry was 
assessed according to gender- and age- specific BMI cutoff points. Among all the 
anthropometric measures and time intervals assessed, weight gain from birth to 
age 2 years was the best predictor of overweight at school age. Similarly, many 
studies in other populations also found early rapid weight gain associated with an 
increased risk of later obesity. Several recent systematic reviews on observational 
studies concluded that rapid weight gain in infancy and the first 2 years of life is a 
significant risk indicator for later adiposity [29–32].
Figure 1 shows the increased odds of later obesity during different age catego-
ries from childhood to adulthood predicted by early rapid weight gain, defined as 
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14 Koletzko et al.
an increase in weight- for- age standard deviation score (SDS) >0.67 SD [29, 33]. In 
addition to an increased obesity risk, high early weight gain in the first 1–2 years of 
life is associated with a variety of other later adverse health outcomes [34–36] such 
as increased risk of high blood pressure [37], increased body fat deposition [28, 
38, 39], less favorable lipoprotein profiles [40], diabetes [41] and asthma [42–44].
Protective Effects of Breastfeeding on Obesity Risk in Later Life
Populations of breastfed infants grow somewhat differently from formula- fed 
populations. In poor populations challenged by high rates of infection and 
diarrhea, the protective effects of breastfeeding against infectious gastroen-
teritis reduces growth faltering and can thus lead to higher mean weight gains 
of breastfed babies than of infants not receiving human milk [45–47]. With 
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Fig. 1. Rapid weight gain in infancy or the first 2 years of life, defined as an increase in 
weight- for- age SDS >0.67 SD, is associated with increased odds of obesity in children, 
teenagers and adults. Redrawn from Adair [33] based on data in Baird et al. [29].
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Early Influences of Nutrition on Postnatal Growth 15
adequate hygienic conditions, however, infants fed conventional infant formula 
achieve a greater gain of bodyweight and weight- for- length during infancy and 
early childhood than breastfed infants [48, 49]. In a systematic review of 19 
studies in affluent populations, the cumulative difference in bodyweight was as 
large as 400 g at one year of age in infants breastfed for 9 months, and even 
600–650 g in infants breastfed for 12 months [50].
Given these marked differences in early growth pattern, we explored the 
potential effects of these early growth differences on later body size. We stud-
ied the relation of breastfeeding with later overweight and obesity risk in a 
cross- sectional survey in Bavaria, Germany [51]. Data on height and weight 
were obtained for 9,357 children participating in the obligatory school health 
examination. Previously breastfed children showed a lower prevalence of both 
overweight (9.2 vs. 12.6%) and obesity (2.8 vs. 4.5%) than formula- fed ones. 
Differences in social class or lifestyle did not explain the protective effect of 
breastfeeding. Children who had ever been breastfed showed a significantly 
reduced adjusted odds ratio (OR) for both overweight (OR 0.79, 95% CI: 0.68–
0.93) and obesity (OR 0.75, 95% CI: 0.57–0.98) as compared to those who were 
never breastfed. The adjusted ORs showed a significant inverse dose- response 
relationship between duration of breastfeeding and both overweight and obe-
sity, which is compatible with a causal effect of breastfeeding or breast milk 
components on obesity reduction (fig. 2).
Many other investigators also explored the relationship between breastfeed-
ing and later obesity in different cohort studies. These have been evaluated in 
0
0.25
0.50
0.75
1.00
<2  3–5 6–12 >12
Duration of breastfeeding (months)
Fig. 2. In a cross- sectional study in >9,000 Bavarian children at school entry, longer dura-
tion of breastfeeding after birth (months) was associated with increasingly reduced odds 
of overweight (black) and obesity (white). Drawn from data of von Kries et al. [51].
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16 Koletzko et al.
several systematic reviews and meta- analyses [45, 46]. We performed a meta- 
analysis of published epidemiological studies (cohort, case- control or cross- 
sectional studies) that included only studies adjusting for at least three relevant 
confounding factors (birthweight, parental overweight, parental smoking, 
dietary factors, physical activity and socioeconomic status/parental educa-
tion) and assessed obesity at an age between 5 and 18 years [52]. Included 
were 9 studies with more than 69,000 children. The result of the meta- analysis 
showed breastfeeding associated with a significant reduction of the risk of obe-
sity in childhood in the fixed model (adjusted OR 0.78, 95% CI: 0.71–0.85). A 
dose- dependent effect of breastfeeding duration on the prevalence of obesity 
was reported in 4 of the 9 studies. Funnel plot regression gave no indication of 
publication bias. Very similar results were published one year later by Harder 
et al. [53] in a meta- analysis with different inclusion criteria and a much 
larger number of studies evaluated. They found breastfeeding associated with 
reduced pooled adjusted OR for later obesity of 0.75 (95% CI: 0.68–0.82) and 
concluded that each additional month of breastfeeding resulted in 4% lower 
obesity prevalence at later ages. In a further meta- analysis, Owen et al. [54] 
confirmed a protective effect of breastfeeding in a meta- analysis based on an 
even larger number of studies that met their inclusion criteria but reported 
a smaller effect size (OR 0.87). In this analysis, 75% of the effect weight was 
contributed by a single large study from the US Women, Infants and Children 
program on low- income women and children [17]. This study included a 
specific US population with a high degree of mixed feeding that might have 
led to results which are not representative of other breastfed populations. A 
more recent cluster randomized study did cast doubt on the protective effect 
of breastfeeding on obesity risk. The trial had been performed in hospitals in 
Belarus that were either assigned to enhanced breastfeeding promotion, or to 
no active intervention [55]. Whereas the intervention achieved a significantly 
longer duration of breastfeeding, there was no effect on obesity prevalence 
at the age of 6.5 years. However, it is important to note that this trial did not 
have sufficient statistical power to answer the question of a protective effect of 
breastfeeding relative to formula feeding, because rates of breastfeeding were 
relatively similar in the intervention and control groups, and the prevalence of 
obesity was low in this population [56]. Of interest, Beyerlein and von Kries 
[56] and Beyerlein et al. [57] found evidence that breastfeeding reduces par-
ticularly the proportion of subjects with a high BMI at later ages, while having 
little effect on the mean BMI.
We conclude that the totality of the evidence shows breastfeeding associated 
with a moderate but consistent protective effect against later obesity. Clearly, 
these findings should encourage the promotion, protection and support of 
breastfeeding, and of ethical approaches to the marketing of breast milk substi-
tutes such as infant formulas and follow- on formulas, which do not undermine 
breastfeeding [58, 59].
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Early Influences of Nutrition on Postnatal Growth 17
Mechanisms of Protective Effects of Breastfeeding: The ‘Early Protein 
Hypothesis’
Understanding the underlying mechanisms as to how breastfeeding protects 
against later obesity could strengthen the conclusions on protective effects of 
breastfeeding, and it might help to extend protective effects to infants that are 
not breastfed for longer time periods by improving practices of feeding for-
mula or complementary foods. Very many factors differ between breastfeed-
ing and bottle feeding; therefore, numerous different hypotheses can be raised 
here [17].
We have previously proposed that the greater weight gain in formula- fed 
infants, relative to breastfed infants, is at least partly caused by the different 
intakes of metabolizable protein [50]. We explored the hypothesis that the usu-
ally 55–80% higher protein supply to formula- fed babies, as compared to breast-
fed infants [60, 61], could enhance both early weight gain and later obesity risk 
(the ‘Early Protein Hypothesis’) [62]. As described above, amino acids stimulate 
the secretion of insulin and IGF- I and positively activate mTORC1; thus, a high 
protein intake in excess of metabolic requirements may increase the concen-
trations of insulin and IGF- I in the circulation (fig. 3). Epidemiological stud-
ies actually found high protein intakes in infancy and the 2nd year, but not of 
energy, fat or carbohydrates, predictive of an early occurrence of the adiposity 
rebound and a high BMI in childhood [63–67].
Higher protein
supply
Increased plasma
and tissue levels
of insulinogenic
amino acids
Enhanced
secretion of
insulin and IGF-I
Weight gain
up to 2 years
Adipogenic
activity
Long-term risk of obesity
and associated disorders
Fig. 3. The Early Protein Hypothesis suggests that a dietary protein supply to infants in 
excess of their metabolic requirements will lead to increased plasma and tissue concen-
trations of insulin- releasing amino acids and an enhanced secretion of insulin and IGF- I, 
which in turn will enhance early weight gain, adipogenic activity and long- term obesity 
risk. Redrawn after Koletzko et al. [23].
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18 Koletzko et al.
We tested the Early Protein Hypothesis in a randomized clinical trial, the 
European Childhood Obesity Project [24] performed as part of a European 
Commission- funded research collaboration [68]. This multicentric RCT was 
set up in study centers in five European countries (Belgium, Germany, Italy, 
Poland, Spain). Eligible for study participation were apparently healthy, term 
infants born from uncomplicated, singleton pregnancies. Formula- fed infants 
received exclusively one of the two randomized formulas at a mean age of 2 
weeks after birth and no later than at the end of the 8th week of life. Breastfed 
children had to be exclusively breastfed for the first 3 months. Infant formulas 
were replaced by follow- on formulas from the 5th month of age onwards.
The lower protein (LP) and higher protein (HP) infant and follow- on for-
mulas had an identical energy density achieved by adaptation of the fat content, 
whereas the protein contents were 1.8 g protein/100 kcal versus 2.9 g protein/100 
kcal in the infant formulas and 2.2 g protein/100 kcal versus 4.4 g protein/kcal 
in the follow- on formulas (table 1). The relative contents of amino acids did not 
differ between all four formulas, e.g. branched- chained amino acids made up 
23% of the protein content in all four formulas (table 1).
A reference group of 619 breastfed infants was recruited, of whom 298 chil-
dren could be followed until the 24 months visit. Complete anthropometric 
follow- up data at 24 months were available for 313 LP infants (follow- up rate = 
58%) and 323 HP infants (59%). The median age at the baseline visit was 16 
days (interquartile range, IQR: 2–29 days). The protein intake was significantly 
different between the two formula groups at all time points up to 12 months 
of age but not thereafter. The difference ranged between 5.5 g per day (95% 
CI: 5.1–5.9) in the first month to 8.5 g (7.8–9.3) at 6 months. Energy intake in 
the LP and HP formula groups was identical at 3, 12, and 24 months, but was 
slightly higher (24 kcal, 95% CI: 6–43) at 6 months of age in the LP formula 
group.
Differences in weight and weight- for- length between the formula groups 
emerged at 6 months of age and remained relatively stable thereafter with a 
decreasing tendency towards the end of the study. At 24 months of age, length 
was not different between the intervention groups. The mean weight attained 
at 24 months was 12.42 and 12.60 kg for the LP and HP groups, respectively. 
HP led to a significantly higher BMI than LP during the intervention period 
from 6 months onwards as well as after the end of the intervention (fig. 4). 
Of interest, the BMI in the LP group was identical to the breastfed group at 
2 years of age. The effect of the intervention was not different among the 
countries for any of the analyzed anthropometric measures. In addition to 
total body growth, also a significant effect on kidney growth was found [69]. 
We estimated the potential impact of the reduced protein intake in infancy on 
obesity in adolescence based on the observed effects of change in weight- for- 
length gain during the first 2 years of life on later obesity in large prospective 
cohort studies, and we calculated an expected reduction of obesity prevalence 
Gillman MW, Gluckman PD, Rosenfeld RG (eds): Recent Advances in Growth Research: Nutritional, Molecular and Endocrine Perspectives. 
Nestlé Nutr Inst Workshop Ser, vol 71, pp 11–27, (DOI: 10.1159/000342533) Nestec Ltd., Vevey/S. Karger AG., Basel, © 2013
D
ow
nl
oa
de
d 
by
: 
UB
 d
er
 L
M
U 
M
ün
ch
en
   
   
   
   
   
   
   
   
   
   
   
   
 
12
9.
18
7.
25
4.
47
 - 
10
/2
0/
20
14
 1
:4
3:
00
 P
M
Early Influences of Nutrition on Postnatal Growth 19
at 14–16 years by 13% [24]. The actual effects of the intervention after the 
early toddler age are currently being explored in a longer term follow- up 
study.
Biochemical and Endocrine Markers
To explore our underlying hypothesis that the effect of dietary protein on 
growth and obesity risk is mediated by amino acid concentrations, insulin and 
IGF- I, we performed respective analyses in venous blood and in urine samples 
that were obtained from participating infants at the age of 6 months and were 
analyzed in one central laboratory [70].
Table 1. Macronutrient and amino acid content of study formulas with LP and HP used in the 
European Childhood Obesity Trial
Infant formula Follow- on formula
LP HP LP HP
Energy, g/100 ml 69.9 69.8 72.7 72.5
Proteins, g/100 ml 1.25 2.05 1.6 3.2
Percent energy 7.1 11.7 8.8 17.6
Lipids, g/100 ml 3.9 3.5 4.0 3.3
Carbohydrates, g/100 ml 7.5 7.5 7.6 7.6
Amino acids 
Glutamic acid, mg/100 ml 286 473 369 738
Proline, mg/100 ml 135 223 174 348
Leucine, mg/100 ml 119 197 154 308
Lysine, mg/100 ml 94 155 121 243
Asparagine, mg/100 ml 89 147 115 230
Valine, mg/100 ml 84 139 108 216
Isoleucine, mg/100 ml 77 128 100 200
Serine, mg/100ml 71 118 92 184
Tyrosine, mg/100 ml 62 103 80 161
Phenylalanine, mg/100 ml 58 97 75 151
Threonine, mg/100 ml 56 92 72 144
Arginine, mg/100 ml 50 74 57 115
Alanine, mg/100 ml 42 69 54 108
Histidine, mg/100 ml 32 53 41 82
Glycine, mg/100 ml 24 40 31 62
Tryptophane, mg/100 ml 22 29 23 46
Cystine + methionine, mg/100 ml 40 66 52 103
Adapted from Koletzko et al. [24] and Socha et al. [71].
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20 Koletzko et al.
Median total amino acid serum concentrations were slightly higher in the 
HP group (3,041 µmol/l, IQR 2,679–3,394) than in the LP group (2,841 µmol/l, 
IQR 2,523–3,186, p < 0.001). Particularly large group differences were found 
for the branched- chain amino acids valine (+42% in HP), leucine (+37%) and 
isoleucine (+32%; table 2). The concentrations of all other essential amino acids 
were at least 10% higher in HP than in LP. In contrast, non- essential amino 
acids were either not different or even lower in the HP group, with the exception 
of tyrosine and asparagine which were both significantly higher. Interestingly 
enough, the total non- essential amino acid concentrations were not higher but 
significantly lower in the HP group (p = 0.001) [70].
Serum urea concentrations were significantly higher in infants fed HP than 
in those fed LP formulas (table 3). In the HP group, the serum concentrations 
of total IGF- I and free IGF- I were about 40% higher than in the LP group (table 
3), while IGF- BP2 concentrations were about 30% lower. The HP group also 
showed a higher urinary C- peptide concentration and C- peptide/creatinine 
ratio, indicating enhanced insulin secretion, as well as a significantly lower 
serum glucose concentration (table 3).
Both formula groups showed differences to the breastfeeding group. 
Generally, parameters of the IGF axis, C- peptide and amino acids were more 
similar between the LP group and the breastfed group. Total IGF- I, free IGF- 
I, and IGF- BP3 levels were all significantly lower – up to almost 60% – in the 
breastfed than in the formula groups (table 3) [70]. Serum glucose, urinary 
C- peptide and the C- peptide/creatinine ratio all differed significantly between 
BM
I S
D
S
–0.5
0
0.5
1 3 6 12 24
***
**
**
Age (months)
LP
HP
Breastfed
Fig. 4. BMI SDS from birth to age 2 years in subjects participating in the European 
Childhood Obesity Project fed breast milk, or randomized to receive for the first year of 
life formulas with LP or HP contents. Formula- fed infants in the HP group showed higher 
BMI values than breastfed infants in infancy and at 2 years of age. The group randomized 
to LP had significantly lower BMI levels than the HP group, and LP normalized BMI levels 
at age 2 years as compared to breastfed subjects. Drawn from data of Koletzko et al. [24].
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Early Influences of Nutrition on Postnatal Growth 21
the breastfed and the formula groups (table 3). Essential amino acids, especially 
branched- chain amino acids, were lower in the breastfed than in the LP group, 
whereas non- essential amino acids had about the same level.
Total IGF- I was found positively correlated with weight- for- length at 6 
(fig. 5), 12, and 24 months, whereas C- peptide showed no association with 
weight- for- length.
Conclusions
Breastfeeding or formula feeding and dietary protein supply in infancy were 
found to markedly affect the metabolic and endocrine response of infants, and 
their growth. HP intakes increase the plasma levels of essential amino acids, 
especially branched- chain amino acids, serum concentrations of total and 
Table 2. Serum amino acid (AA) concentrations in infants aged 6 months fed HP and LP for-
mula, and in breastfed infants (BF)
LP HP p value  
(HP vs. LP)
BF
Essential amino acids
ILE, µmol/l 64 (50, 80)a 85 (62, 114)f <0.001 58 (46, 74)
LEU, µmol/l 120 (98, 143)b 165 (124, 212)f <0.001 106 (90, 133)
LYS, µmol/l 166 (134, 197)c 197 (156, 248)f <0.001 145 (121, 184)
MET, µmol/l 31 (26, 39)c 35 (26, 46)f <0.001 27 (22, 35)
PHE, µmol/l 72 (61, 83)c 84 (70, 100)f <0.001 61 (48, 74)
THR, µmol/l 126 (101, 154) 142 (118, 173)f <0.001 119 (92, 150)
TRP, µmol/l 56 (47, 67)b 67 (54, 82)f <0.001 60 (50, 74)
VAL, µmol/l 214 (182, 247)c 304 (241, 376)f <0.001 172 (143, 208)
Non- essential amino acids
ALA, µmol/l 440 (346, 526) 420 (349, 517) 0.304 430 (355, 495)
ARG, µmol/l 115 (97, 137) 110 (91, 128) 0.038 113 (91, 129)
ASN, µmol/l 54 (45, 64) 58 (47, 68)e 0.015 52 (45, 64)
ASP, µmol/l 25 (17, 35) 27 (19, 35) 0.143 26 (18, 38)
GLN, µmol/l 605 (542, 683)c 556 (490, 613)f <0.001 664 (573, 748)
GLU, µmol/l 122 (95, 168) 115 (88, 172) 0.179 130 (90, 193)
GLY, µmol/l 267 (217, 319)c 230 (199, 273)d <0.001 220 (185, 264)
HIS, µmol/l 105 (88, 123)c 107 (93, 124)f 0.215 88 (74, 105)
SER, µmol/l 161 (138, 194)c 159 (140, 189)f 0.750 187 (156, 207)
TYR, µmol/l 83 (70, 103)c 101 (76, 125)f <0.001 66 (54, 80)
Adapted from Socha et al. [71]. Values are expressed as median (IQR, 25th, 75th quartile). 
a p < 0.05, LP vs. BF; b p < 0.01, LP vs. BF; c p < 0.001, LP vs. BF; d p < 0.05, HP vs. BF;  
e p < 0.01, HP vs. BF; f p < 0.001, HP vs. BF.
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free IGF- I, and urinary C- peptide levels which reflect increased insulin secre-
tion, while the serum glucose level was lowered. Using infant formula with LP 
content results in a more similar – but not equal – metabolic and endocrine 
response as compared to breastfed infants, while it normalizes weight and BMI 
of formula- fed babies relative to healthy breastfed subjects during the first 2 
years of life.
The observed marked effects of formula protein contents on total and free IGF- I 
agree with earlier observations of lower IGF- I levels in breastfed compared to 
formula- fed infants, and in some studies with varying protein intakes, as reviewed 
by Socha et al. [71]. The observed correlation of IGF- I levels with weight- for- length 
leads us to conclude that IGF- I is a key driver of weight gain during infancy, which 
clearly can be modulated to a biologically relevant extent by dietary composition. 
In addition to modulating growth, elevated IGF- I levels in infancy may also have 
further long- term effects. Formula feeding, HP intakes, and higher IGF- I levels in 
infancy have been associated with lower IGF- I levels in later life [72–75], whereas 
breastfeeding is associated with lower IGF- I in infancy but higher IGF- I in later 
childhood [72]. In healthy adults, a lower IGF- I concentration has been associated 
with an increased risk of both ischemic heart disease and diabetes [76] as well as 
with increased incidence of malignancies such as prostate and breast cancer [77]. 
Therefore, programming of the IGF- I axis through early nutrition in infancy may 
have a considerable impact on the later risk not only of obesity but also of other 
Table 3. Serum concentrations of free and total IGF- I IGF- BP2 and IGF- BP3, glucose and urea, 
and of urinary C- peptide in infants on LP and HP and in BF infants 
Parameter LP HP P (HP 
vs. LP)
BF
IGF- I free, ng/ml 0.43 (0.27, –0.77)a 0.60 (0.34, 1.11)b <0.001 0.31 (0.21, 0.48)
IGF- I total, ng/ml 34.7 (17.7, 57.5)a 48.4 (27.2, 81.8)b <0.001 14.1 (5.1, 33.2)
IGF- BP2, ng/ml 1,090 (865, 1,438) 765 (575, 1,013) <0.001 1,370 (1,055, 1,740)
IGF- BP3, ng/ml 2,908 (2,449, 3,440) 2,969 (2,538, 3,483) 0.248 2,454 (1,984, 2,794)
C- peptide/
creatinine ng/mg 
107.3 (65.2, 194.7)a 140.6 (80.0, 203.8)b 0.030 57.0 (27.3, 119.3)
C- peptide, ng/ml 19.5 (9.4, 34.6)a 26.9 (13.3, 45.6)b 0.002 9.3 (3.5, 20.1)
Glucose, mg/dl 85 (77, 93) 83 (77, 89)b 0.022 86 (79, 93)
Urea, mg/dl 18 (14, 21)a 29 (20, 36)b <0.001 11 (8, 16)
Adapted from Socha et al. [71]. Values are expressed as median (IQR, 25th, 75th quartile). 
a p < 0.001, LP vs. BF; b p < 0.001, HP vs. BF.
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adult diseases [72]. While lowering protein supply decreased IGF- I levels, these 
still remained far higher than the levels observed in breastfed babies. Thus, further 
exploration of the regulators of the IGF- I axis in early life is needed, including the 
investigation of the effects of IGF gene variants on IGF- I and its binding proteins, 
and their interaction with nutrition and growth.
Given that insulin plays a central role in metabolic regulation, IGF- I tran-
scription and enhanced body fat deposition, the observed increased C- peptide 
levels by HP intake might also induce lasting effects on growth and health out-
comes. Attenuation of the elevated insulin secretion though optimized early 
nutrition, such as LP intake in formula- fed babies, seems desirable. In addition 
to reducing protein supply with infant formula, the use of unmodified cows’ 
milk as a drink during the first year of life, which provides very high protein 
intake, should be discouraged [78].
The available data should prompt enhanced efforts to actively promote, pro-
tect and support breastfeeding. For those infants that are not breastfed or not 
fully breastfed, we consider the use of infant formulas with reduced protein con-
tent but high protein quality preferable.
Appendix
The European Childhood Obesity Project Study Group
Philippe Goyens, Clotilde Carlier, Joana Hoyos (ULB, Bruxelles, Belgium), Françoise 
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Fig. 5. At the age of 6 months, total IGF- I (log scale) is a significant predictor of weight- 
for- length (WFL) SDS in 513 infants participating in the European Childhood Obesity Trial 
(rho = 0.24, p < 0.001). Drawn from data of Socha et al. [70].
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